Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy S, The association of antineutrophil cytoplasmic autoantibodies (ANCA) with systemic sclerosis (SSc) is very infrequent with only a few cases reported in the literature [1] [2] [3] . We report one patient with SSc and necrotizing glomerulonephritis in whom p-ANCA were detected. Moreover, the patient developed clinical Paget's disease after the immunosuppressive therapy, which may have played a part in the development of the disease.
A 60-yr-old female with a 12-month history of Raynaud's phenomenon, chronic coughing, sclerodactyly, antinuclear antibodies (ANA) and anti-Scl 70 antibodies, presented to our clinic. Radiological examination and bronchoalveolar lavage revealed interstitial pneumonitis as a complication of SSc and she was started on prednisone (1 mg/kg/daily). Owing to the presence of hypertension, haematuria and proteinuria, a diagnosis of scleroderma renal crisis was reached and captopril (50 mg/day) was added to decreasing corticosteroid therapy, with control of blood pressure. One year later, while she was on deflazacort (6 mg daily), she had a rapid renal function impairment. Her physical examination revealed a blood pressure of 140/80 mmHg, microstomia, sclerodactyly, purpuric lesions over the lower extremities and crackling rales on pulmonary auscultation. Blood tests showed: haemoglobin: 11.1 g/dl (12-16), urea: 82 mg/dl (18-50), creati- of sodium etidronate adjusted for renal failure Anti-SSA, anti-SSB, anti-RNP, anti-DNA and anti-Sm (3 mg/kg/daily) was added to corticosteroid therapy. were negative.
Serum alkaline phosphatase and pyridinoline levels Skin biopsy showed a leucocytoclastic vasculitis decreased after the etidronate therapy (246 U/l and and renal biopsy revealed necrotizing glomeruloneph-40 n/m Cr, respectively). ritis with extracapillary proliferation compatible with
The association of p-ANCA with SSc is very infrevasculitis, and she was started on corticosteroids quent with only a few cases being reported in the (1 mg/kg/daily) and cyclophosphamide (0.75 g/m2 literature [1] [2] [3] . Its presence has been found to be highly monthly for 6 months and then every 3 months for specific for normotensive renal failure associated with 1 yr). Renal function improved and ANCA became SSc, and its titres were correlated with renal disease negative after the fifth cyclophosphamide pulse. Ten activity [1] . months after the immunosuppressive therapy interrupSeveral distinctions have been found between renal tion, while she was on deflazacort 12 mg daily, blood SSc associated with p-ANCA and scleroderma kidney chemistries showed a progressive increase in serum [4, 5] . Scleroderma kidney is characterized by acceleralkaline phosphatase (highest reached value: 540 U/l ). ated to malignant hypertension, progressive renal Pyridinoline and acid phosphatase were also elevated:
insufficiency, hyper-reninaemia and microangiopathic 66.31 n/m Cr (16-45) and 6 U/l (0-5.5), respectively.
haemolysis [1, 5, 6 ] . Histopathological study reveals an Radiological examination showed a disorganized intimal fibrosis with fibrinoid necrosis of the media, trabecular pattern in the right ischium and thickening mainly in the interlobular and arcuate arteries. However, of the innominate line, that she did not have in previous renal SSc associated with p-ANCA is characterized by X-rays (Fig. 1) . Radionuclide bone scan revealed an rapidly progressive renal insufficiency without malignant increased uptaking in the right ischium, pathognomonic hypertension and with normal plasma renin activity. for Paget's disease. Because of Paget's disease activity, Renal histology shows crescentic necrotizing lesions with minimal immune deposits, but no arterial or arteriolar although the patient was asymptomatic, a low dose gations could be performed. Results of these studies suggest that anti-MPO antibodies must be investigated in patients with SSc and normotensive renal failure. The association of optic neuropathy with transverse Our patient had the peculiarity of developing Paget's myelitis in systemic lupus erythematosus disease 10 months after the cyclophosphamide therapy interruption and while she was on low steroid doses.
S, Central nervous system (CNS) involvement is Whether immunosuppressive therapy might play a part common in systemic lupus erythematosus (SLE), and in activating quiescent Paget's disease remains unclear.
at present it remains one of the major causes of morbidSeveral observations suggest that Paget's disease may ity and mortality in these patients. CNS lupus includes be caused by a viral infection [7] [8] [9] . If this hypothesis a wide range of clinical manifestations, such as neurois true, immunosuppression may cause an activation of logical features, psychiatric disorders and severe cognitive a quiescent disease. Moreover, steroid therapy inhibits involvement. Different mechanisms have been invoked several proinflammatory cytokines such as interleukin to explain CNS disease in SLE, but at present some (IL)-6 or IL-1 [10] . Recent studies suggest that cytoquestions still remain unanswered. kines, such as IL-6, could be responsible for bone Alarcó n-Segovia [1] underlined that peculiar mechanremodelling disorders in Paget's disease. It is possible isms may participate; in particular, these include immune that high daily steroids, which were administered to the complex deposition in the choroid plexus and vascular patient at the beginning, originated a cytokine inhibition disease which may be due to vasculitis, embolism and that could inhibit Paget's disease reactivation.
arterial and/or venous thrombosis. CNS vasculopathy Finally, bone fragility due to corticoid therapy in the could be due to anti-endothelial cell and antiphosphoaffected pagetic bone could produce microfractures; this lipid antibodies (aPL). Interestingly, aPL might interact situation, and the lack of cytokine inhibition due to low on CNS phospholipids and might determine transverse steroid doses administrated after the immunosuppressive myelitis ( TM ). Furthermore, anti-neuronal antibodies therapy was withdrawn, may have stimulated Paget's have been well described in SLE patients; they may disease activity.
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suffering from 'focal' brain disease plus aPL, anticoagu-
